Tandem Diabetes Care (TNDM) Short term Debt (2024 - 2025)
Tandem Diabetes Care's (TNDM) quarterly Short term Debt came in at $40.7 million in Q1 2025, little changed on a QoQ basis from $40.7 million in Q4 2024.
Tandem Diabetes Care (TNDM) Short term Debt (2024 - 2025) Analysis & Trends
Tandem Diabetes Care (TNDM) has 2 years of Short term Debt data on file, last reported at $40.7 million in Q1 2025.
- Quarterly Short term Debt changed N/A year-over-year to $40.7 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $40.7 million (changed N/A YoY) and the FY2024 annual result came in at $40.7 million, changed N/A from the prior year.
- Short term Debt was little changed at $40.7 million in Q1 2025, from $40.7 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $40.7 million in Q1 2025 to a low of $40.5 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.57 Bn | 1.11 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 40.74 Mn |
| Dec 31, 2024 | 40.67 Mn |
| Sep 30, 2024 | 40.61 Mn |
| Jun 30, 2024 | 40.54 Mn |